drugset / Trial / NCT00793910

Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy

NCT00793910

Completed 106 enrolled Walter Reed Army Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of an oral medication called gabapentin in reducing pain after Photorefractive Keratectomy (PRK) eye surgery and to assess the frequency of use of rescue medication interventions, defined as non-steroidal anti-inflammatory (NSAID) eye drops and oral narcotic medication.

Timeline

Start
2008-07
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 300 mg Oral

Indications

No indication recorded.